 Revolution Medicines, Inc. NASDAQ:RVMD Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Margaret Horn - Chief Operating Officer Mark Goldsmith - Chairman Chief Executive Officer Jack Anders - Senior Vice President of Finance Principal Accounting Officer Steve Kelsey - President of RD Conference Call Participants Alec Stranahan - Bank of America Faisal Khurshid - SVB Securities Eric Joseph - JPMorgan Marc Frahm - Cowen Michael Schmidt - Guggenheim Partners Chris Shibutani - Goldman Sachs Jay Olson - Oppenheimer Operator Good day and thank you for standing by. Welcome to the Revolution Medicines Third Quarter 2022 Earnings Webcast. 